Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice dataLinde E. M. de Wijs, DirkJan Hijnen, Angela L. Bosma et al.|British Journal of Dermatology|2019Cited by 92
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L. Bosma, Phyllis I. Spuls, Linde E. M. de Wijs et al.|Journal of the American Academy of Dermatology|2020Cited by 58
<scp>TRE</scp> atment of <scp>AT</scp> opic eczema ( <scp>TREAT</scp> ) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF.M. Vermeulen, Louise A. A. Gerbens, Angela L. Bosma et al.|British Journal of Dermatology|2019Cited by 38
Measuring Atopic Eczema Control and Itch Intensity in Clinical PracticeYael A. Leshem, Hywel C Williams, Eric L. Simpson et al.|JAMA Dermatology|2022Cited by 36
Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case seriesAngela L. Bosma, Phyllis I. Spuls, Louise A. A. Gerbens et al.|Clinical and Experimental Dermatology|2021Cited by 29